List of Tables
Table 1. Global Graves Disease Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Graves Disease Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Graves Disease Treatment Market Competitive Situation by Manufacturers in 2024
Table 4. Global Graves Disease Treatment Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Graves Disease Treatment Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Graves Disease Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Graves Disease Treatment Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Graves Disease Treatment Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Graves Disease Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Graves Disease Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Graves Disease Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Graves Disease Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Graves Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Graves Disease Treatment as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Graves Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Graves Disease Treatment Sales by Region (2020-2025) & (K Units)
Table 18. Global Graves Disease Treatment Sales Market Share by Region (2020-2025)
Table 19. Global Graves Disease Treatment Sales by Region (2026-2031) & (K Units)
Table 20. Global Graves Disease Treatment Sales Market Share by Region (2026-2031)
Table 21. Global Graves Disease Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Graves Disease Treatment Revenue Market Share by Region (2020-2025)
Table 23. Global Graves Disease Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Graves Disease Treatment Revenue Market Share by Region (2026-2031)
Table 25. North America Graves Disease Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Graves Disease Treatment Sales by Country (2020-2025) & (K Units)
Table 27. North America Graves Disease Treatment Sales by Country (2026-2031) & (K Units)
Table 28. North America Graves Disease Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Graves Disease Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Graves Disease Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Graves Disease Treatment Sales by Country (2020-2025) & (K Units)
Table 32. Europe Graves Disease Treatment Sales by Country (2026-2031) & (K Units)
Table 33. Europe Graves Disease Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Graves Disease Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Graves Disease Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Graves Disease Treatment Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Graves Disease Treatment Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Graves Disease Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Graves Disease Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Graves Disease Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Graves Disease Treatment Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Graves Disease Treatment Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Graves Disease Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Graves Disease Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Graves Disease Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Graves Disease Treatment Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Graves Disease Treatment Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Graves Disease Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Graves Disease Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Graves Disease Treatment Sales (K Units) by Type (2020-2025)
Table 51. Global Graves Disease Treatment Sales (K Units) by Type (2026-2031)
Table 52. Global Graves Disease Treatment Sales Market Share by Type (2020-2025)
Table 53. Global Graves Disease Treatment Sales Market Share by Type (2026-2031)
Table 54. Global Graves Disease Treatment Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Graves Disease Treatment Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Graves Disease Treatment Revenue Market Share by Type (2020-2025)
Table 57. Global Graves Disease Treatment Revenue Market Share by Type (2026-2031)
Table 58. Global Graves Disease Treatment Price (US$/Unit) by Type (2020-2025)
Table 59. Global Graves Disease Treatment Price (US$/Unit) by Type (2026-2031)
Table 60. Global Graves Disease Treatment Sales (K Units) by Application (2020-2025)
Table 61. Global Graves Disease Treatment Sales (K Units) by Application (2026-2031)
Table 62. Global Graves Disease Treatment Sales Market Share by Application (2020-2025)
Table 63. Global Graves Disease Treatment Sales Market Share by Application (2026-2031)
Table 64. Global Graves Disease Treatment Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Graves Disease Treatment Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Graves Disease Treatment Revenue Market Share by Application (2020-2025)
Table 67. Global Graves Disease Treatment Revenue Market Share by Application (2026-2031)
Table 68. Global Graves Disease Treatment Price (US$/Unit) by Application (2020-2025)
Table 69. Global Graves Disease Treatment Price (US$/Unit) by Application (2026-2031)
Table 70. Abbott Company Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Abbott Graves Disease Treatment Product
Table 74. Abbott Recent Developments/Updates
Table 75. Merck & Co Company Information
Table 76. Merck & Co Description and Business Overview
Table 77. Merck & Co Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Merck & Co Graves Disease Treatment Product
Table 79. Merck & Co Recent Developments/Updates
Table 80. Pfizer, Inc Company Information
Table 81. Pfizer, Inc Description and Business Overview
Table 82. Pfizer, Inc Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Pfizer, Inc Graves Disease Treatment Product
Table 84. Pfizer, Inc Recent Developments/Updates
Table 85. AbbVie, Inc Company Information
Table 86. AbbVie, Inc Description and Business Overview
Table 87. AbbVie, Inc Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. AbbVie, Inc Graves Disease Treatment Product
Table 89. AbbVie, Inc Recent Developments/Updates
Table 90. Mylan N.V Company Information
Table 91. Mylan N.V Description and Business Overview
Table 92. Mylan N.V Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Mylan N.V Graves Disease Treatment Product
Table 94. Mylan N.V Recent Developments/Updates
Table 95. Allergan, plc Company Information
Table 96. Allergan, plc Description and Business Overview
Table 97. Allergan, plc Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Allergan, plc Graves Disease Treatment Product
Table 99. Allergan, plc Recent Developments/Updates
Table 100. Novartis AG Company Information
Table 101. Novartis AG Description and Business Overview
Table 102. Novartis AG Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Novartis AG Graves Disease Treatment Product
Table 104. Novartis AG Recent Developments/Updates
Table 105. Apitope Company Information
Table 106. Apitope Description and Business Overview
Table 107. Apitope Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Apitope Graves Disease Treatment Product
Table 109. Apitope Recent Developments/Updates
Table 110. Amgen INC. Company Information
Table 111. Amgen INC. Description and Business Overview
Table 112. Amgen INC. Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Amgen INC. Graves Disease Treatment Product
Table 114. Amgen INC. Recent Developments/Updates
Table 115. Sun Pharmaceuticals Industries LTD Company Information
Table 116. Sun Pharmaceuticals Industries LTD Description and Business Overview
Table 117. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product
Table 119. Sun Pharmaceuticals Industries LTD Recent Developments/Updates
Table 120. Immunovant Inc Company Information
Table 121. Immunovant Inc Description and Business Overview
Table 122. Immunovant Inc Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Immunovant Inc Graves Disease Treatment Product
Table 124. Immunovant Inc Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Graves Disease Treatment Distributors List
Table 128. Graves Disease Treatment Customers List
Table 129. Graves Disease Treatment Market Trends
Table 130. Graves Disease Treatment Market Drivers
Table 131. Graves Disease Treatment Market Challenges
Table 132. Graves Disease Treatment Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Graves Disease Treatment
Figure 2. Global Graves Disease Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Graves Disease Treatment Market Share by Type: 2024 & 2031
Figure 4. Anti-Thyroid Medication Product Picture
Figure 5. Radioactive Iodine Therapy Product Picture
Figure 6. Global Graves Disease Treatment Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Graves Disease Treatment Market Share by Application: 2024 & 2031
Figure 8. Hospitals Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Global Graves Disease Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Graves Disease Treatment Market Size (2020-2031) & (US$ Million)
Figure 12. Global Graves Disease Treatment Sales (2020-2031) & (K Units)
Figure 13. Global Graves Disease Treatment Average Price (US$/Unit) & (2020-2031)
Figure 14. Graves Disease Treatment Report Years Considered
Figure 15. Graves Disease Treatment Sales Share by Manufacturers in 2024
Figure 16. Global Graves Disease Treatment Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Graves Disease Treatment Players: Market Share by Revenue in Graves Disease Treatment in 2024
Figure 18. Graves Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Graves Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Graves Disease Treatment Sales Market Share by Country (2020-2031)
Figure 21. North America Graves Disease Treatment Revenue Market Share by Country (2020-2031)
Figure 22. United States Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Graves Disease Treatment Sales Market Share by Country (2020-2031)
Figure 25. Europe Graves Disease Treatment Revenue Market Share by Country (2020-2031)
Figure 26. Germany Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Graves Disease Treatment Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Graves Disease Treatment Revenue Market Share by Region (2020-2031)
Figure 33. China Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Graves Disease Treatment Sales Market Share by Country (2020-2031)
Figure 43. Latin America Graves Disease Treatment Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Graves Disease Treatment Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Graves Disease Treatment Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Graves Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Graves Disease Treatment by Type (2020-2031)
Figure 53. Global Revenue Market Share of Graves Disease Treatment by Type (2020-2031)
Figure 54. Global Graves Disease Treatment Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Graves Disease Treatment by Application (2020-2031)
Figure 56. Global Revenue Market Share of Graves Disease Treatment by Application (2020-2031)
Figure 57. Global Graves Disease Treatment Price (US$/Unit) by Application (2020-2031)
Figure 58. Graves Disease Treatment Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
